Utilization of Hepatitis C Positive Kidneys in Negative Recipients

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University
Study ID
NCT03801707
Phase
PHASE2/PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To evaluate the safety and feasibility of transplanting kidneys from Hepatitis C virus (HCV) infected donors into recipients without HCV infection

Key Dates

Start date
Mar 22, 2019
Status verified
Aug 2023
Primary completion
Apr 28, 2021
Completion
Apr 30, 2021

Study Design

Enrollment
54 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention group
    kidney transplant recipients who receive kidney allograft from hepatitis C viremic donors followed by treatment with direct acting antiviral therapies.

Primary Outcome Measure

Proportion of Patients With Undetectable Hepatitis C Virus (HCV) Polymerase Chain Reaction (PCR) at 12 Weeks After Completion of HCV Treatment [ Time Frame: 12 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Brenda CusonColumbusOhio43210-

Find similar trials in Columbus, OH

By research site
Brenda Cuson· Columbus, OH

Related Studies